Meet the team
Animesh Poddar, PhD
President & Founder
Dr. Animesh Poddar has more than 17 years of biopharmaceutical industry experience in various areas of strategic analytics. He currently serves as a consultant for scouting, forecasting, evaluating and financial modeling for various clients.
Dr. Poddar has held several strategic and analytics positions with Roche, GlaxoSmithKline (GSK) and, most recently, AstraZeneca, where he has had direct, hands-on involvement in forecasting, sales & marketing costs estimation, commercial evaluation, decision tree risk and financial evaluation of opportunities and deal structure development (complex forecasting and financial modeling) for business development and licensing. As a strategic player in sales operations, he has been instrumental in engineering field experiments design and analyses, targeting, alignment, incentive compensation, reporting, and sales force structure and size. Dr. Poddar provides support in commercial analytics with marketing mix modeling, promotional strategy and optimization, promotional effectiveness and ROI, and regional strategic analyses. He’s held a key role in signing several deals totaling more than $3.5 billion, including: the acquisition of Ardea BioSciences and Omthera Pharmaceuticals; out-licensing of Nexium OTC to Pfizer (global) and Forxiga to Ono (Japan); the in-licensing of WEE1 inhibitor from Merck and Fentanyl nasal spray from Archimedes (Australia); a multi-asset co-development and co-promotion deal with Amgen; and, deals on several early stage assets and platforms.
Dr. Poddar received his PhD in Pharmacology from the University of Georgia followed by an MBA from Bowling Green State University. After finishing his BS in Pharmacy from Jadavpur University, India, he worked as a sales representative for Winthrop Pharmaceuticals.